CN111440241B - 一种包含特异性结合ros1的单克隆抗体的癌症检测试剂盒 - Google Patents
一种包含特异性结合ros1的单克隆抗体的癌症检测试剂盒 Download PDFInfo
- Publication number
- CN111440241B CN111440241B CN202010481249.4A CN202010481249A CN111440241B CN 111440241 B CN111440241 B CN 111440241B CN 202010481249 A CN202010481249 A CN 202010481249A CN 111440241 B CN111440241 B CN 111440241B
- Authority
- CN
- China
- Prior art keywords
- monoclonal antibody
- ros1
- cells
- antibody
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/10—Protein-tyrosine kinases (2.7.10)
- C12Y207/10001—Receptor protein-tyrosine kinase (2.7.10.1)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/82—Translation products from oncogenes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
稀释倍数 | OD值 |
500 | 1.936 |
1000 | 1.705 |
2000 | 1.556 |
4000 | 1.407 |
8000 | 1.026 |
16000 | 0.829 |
对照 | 0.093 |
空白对照 | 0.021 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010481249.4A CN111440241B (zh) | 2020-05-31 | 2020-05-31 | 一种包含特异性结合ros1的单克隆抗体的癌症检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010481249.4A CN111440241B (zh) | 2020-05-31 | 2020-05-31 | 一种包含特异性结合ros1的单克隆抗体的癌症检测试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111440241A CN111440241A (zh) | 2020-07-24 |
CN111440241B true CN111440241B (zh) | 2021-01-05 |
Family
ID=71657689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010481249.4A Active CN111440241B (zh) | 2020-05-31 | 2020-05-31 | 一种包含特异性结合ros1的单克隆抗体的癌症检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111440241B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113476601B (zh) * | 2021-08-24 | 2022-05-20 | 知佰幸细胞库(浙江)有限公司 | 干细胞细胞因子联合海藻多糖制备的药物或化妆品 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120208824A1 (en) * | 2006-01-20 | 2012-08-16 | Cell Signaling Technology, Inc. | ROS Kinase in Lung Cancer |
CN108997502A (zh) * | 2018-08-09 | 2018-12-14 | 靖江市人民医院 | 鼠抗人ros1蛋白单克隆抗体制备及其免疫组化用途 |
-
2020
- 2020-05-31 CN CN202010481249.4A patent/CN111440241B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN111440241A (zh) | 2020-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107022029B (zh) | 高特异高灵敏检测甲胎蛋白的单克隆抗体及试剂盒和应用 | |
CN107709359A (zh) | Ror1‑ror2结合的调节剂 | |
EP3089993A1 (en) | Anti-vegf antibodies and use thereof | |
CN103201290A (zh) | S100a4抗体及其治疗用途 | |
CN110194787A (zh) | 靶向抑制Wnt/β-catenin信号活性的多肽及其用途 | |
US20100151486A1 (en) | Osteopontin functional epitopes, monoclonal antibodies against the epitopes and uses thereof | |
CN113150142A (zh) | 一种用于检测血清中pf4含量的抗体对及其用途 | |
WO2022179516A1 (zh) | 抗TrkA抗体或其抗原结合片段、其制备方法和应用 | |
CN111440241B (zh) | 一种包含特异性结合ros1的单克隆抗体的癌症检测试剂盒 | |
WO2014169494A1 (zh) | 特异性识别egfr突变蛋白的单克隆抗体、制备方法及其应用 | |
CN108424455A (zh) | 一种肿瘤标志物CA50检测用抗体IgG及应用 | |
CN103059137A (zh) | 抗hIL6R高亲和力抗体的制备及应用 | |
CN114195888B (zh) | 一种抗新冠抗体药物的核心序列 | |
CN113527479B (zh) | 特异结合电压门控钠离子通道α亚基Nav1.7的抗体或抗体片段 | |
CN107916254A (zh) | Homer1单克隆抗体及其应用 | |
WO2014047973A1 (zh) | 特异性识别B-Raf突变蛋白的单克隆抗体、制备方法及其应用 | |
CN103897061B (zh) | 阻断西妥昔单抗和egfr结合的抗体、其试剂盒及杂交瘤细胞 | |
US11175289B2 (en) | Application of TRPM8 protein, related peptide fragment and their antibodies | |
WO2015165368A1 (zh) | 抗her2中和活性单克隆抗体及其应用 | |
CN112724253B (zh) | 抗人穹窿体蛋白的抗体及其应用 | |
CN112143805A (zh) | Rit1在肝细胞癌的诊断和治疗中的应用 | |
CN110066770A (zh) | 分泌莱克多巴胺单克隆抗体的杂交瘤细胞株、单克隆抗体及应用 | |
CN105085648B (zh) | 抗卵巢癌单抗coc166-9的对应抗原及其应用 | |
CN109679924A (zh) | 高亲和力抗人和肽素的单克隆抗体及其制备方法与应用 | |
CN108997502A (zh) | 鼠抗人ros1蛋白单克隆抗体制备及其免疫组化用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Taihua Inventor after: Shi Xinyi Inventor after: Peng Fei Inventor after: Gu Chao Inventor before: Peng Fei Inventor before: Gu Chao |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20201218 Address after: 523000 401, room 4, building 10, innovation and Technology Park, Songshan Lake high tech Industrial Development Zone, Dongguan, Guangdong, China Applicant after: Guangdong cel Biotechnology Co.,Ltd. Address before: 4315, 4th Floor, Building No. 7, Fengxianzhong Road, Haidian District, Beijing, 100000 Applicant before: BEIJING YUEHAO TECHNOLOGY DEVELOPMENT Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: Room 401, Building 10, No. 6, Hongmian Road, Songshan Lake Park, Dongguan City, Guangdong 523000 Patentee after: Guangdong cel Biotechnology Co.,Ltd. Address before: 523000 401, room 4, building 10, innovation and Technology Park, Songshan Lake high tech Industrial Development Zone, Dongguan, Guangdong, China Patentee before: Guangdong cel Biotechnology Co.,Ltd. |